Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed the stock exchanges that its Board of Directors will meet on Thursday, 29 January 2026. The main item on the agenda is to approve the Un-Audited Financial Results for the quarter and nine months ended 31 December 2025 (Q3 FY26 results). The meeting also has a standard 'any other matter with permission of the board' clause. The intimation has been filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, signed by Director Aman Patel. The company is listed on BSE (Scrip Code: 539470), Calcutta Stock Exchange, and Metropolitan Stock Exchange.
This is a routine advance intimation and typically has no immediate effect on the stock. The Q3 FY26 results, when announced on or after 29 January, will be the next catalyst for the stock. Investors should watch the actual results for revenue, profitability, and any business updates that may emerge from the meeting.